Athersys closing in on commercialization of its stem cell therapy

The Cleveland company said its Japanese partner has completed follow-up examinations of ischemic stroke patients who were treated with MultiStem.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news